Unicycive Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +1,138.5% | +76.4% | +50.7% | +33.6% | |
| – | – | +866.7% | +316.4% | +8.4% | +68.8% | +33.0% | +12.4% | |
| – | +159.0% | +33.5% | +391.0% | – | – | – | – | |
| – | +4,983.3% | -154.4% | – | – | -107.9% | – | – | |
| – | +0.0% | +0.0% | +0.0% | -93.1% | +500.0% | +500.0% | -66.7% | |
| – | +0.0% | +0.0% | +0.0% | -93.1% | +500.0% | +500.0% | +16,698.6% | |
| – | – | – | – | – | – | +26.3% | -100.0% | |
| – | +158.2% | +0.0% | -101.1% | -100.0% | – | – | – | |
| – | +45.8% | +23.8% | +1,449.5% | -102.1% | – | +63.7% | +3.1% | |
| – | -140.0% | – | – | -197.3% | – | +77.8% | -81.4% | |
| – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.